Skip to main content
. 2021 Jul 28;11:702400. doi: 10.3389/fonc.2021.702400

Table 1.

General patient information.

Number Sex Age (years) TNM staging Tumor location Radiotherapy technique Chemotherapy protocol
Patient 1 Male 62 T4N1M0 Mid-thoracic IMRT Docetaxel+nedaplatin
Patient 2 Male 44 T3N1M0 Mid-thoracic 3D-CRT Docetaxel+cisplatin
Patient 3 Male 75 T4N1M0 Cervical 3D-CRT Cisplatin+tegafur
Patient 4 Male 62 T2N1M1 Upper thoracic IMRT Docetaxel+nedaplatin
Patient 5 Male 60 T4N1M1 Mid-thoracic IMRT Docetaxel+nedaplatin
Patient 6 Male 66 T3N1M0 Mid-thoracic IMRT Docetaxel+nedaplatin
Patient 7 Male 53 T3N3M1 Mid-thoracic IMRT Docetaxel+nedaplatin
Patient 8 Male 54 T4N1M0 Upper thoracic 3D-CRT Docetaxel+nedaplatin
Patient 9 Male 67 T3N1M0 Upper thoracic 3D-CRT Cisplatin+tegafur
Patient 10 Male 64 T3N1M0 Upper thoracic 3D-CRT Docetaxel+nedaplatin
Patient 11 Male 61 T3N1M0 Cervical 3D-CRT Docetaxel+nedaplatin
Patient 12 Male 56 T4N1M1 Mid-thoracic IMRT Docetaxel+nedaplatin
Patient 13 Male 60 T3N1M1 Upper thoracic IMRT Docetaxel+nedaplatin
Patient 14 Male 50 T4N1M0 Cervical IMRT Docetaxel+nedaplatin
Patient 15 Male 62 T3N1M0 Upper thoracic IMRT Docetaxel+nedaplatin
Patient 16 Male 61 T3N1M1 Upper thoracic IMRT Docetaxel+nedaplatin